All In MedTech

Device Trial Radar · NCT07828730

Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 1,000 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

1,000

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Dec 2027

Study completion Mar 2028

Sponsor

Lead sponsor
Sunnybrook Health Sciences CentreAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
KMH Cardiology and Diagnostic Centres; Sparrow Acoustics Inc.; Ontario Health; Canadian Cardiovascular Society; Edwards life sciences; Medtronic
First posted
Sep 18, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Screening
FDA-regulated device
No
Who can join
All sexes, from 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this research is to look at an approved intervention (Stethophone application) to obtain additional information about improving detection of moderate or severe aortic stenosis when compared with usual standard of care.

Conditions

  • Moderate or Severe Aortic Stenosis

Interventions

  • StethophoneDevice

    Stethophone is a smartphone application developed by Sparrow Acoustics Inc. It turns a smartphone into a digital stethoscope. Stethophone is cleared by the U.S. FDA and licensed by Health Canada to record heart sounds and detect heart murmurs. It is not cleared or licensed to diagnose aortic stenosis. In this study, Stethophone is used as a digital auscultation decision-support device, and its output is not a diagnosis. An abnormal result prompts transthoracic echocardiography, which is used to confirm moderate or severe aortic stenosis.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of new diagnosis of moderate or severe aortic stenosis on transthoracic echo/1000 patients screened of patients over 70 yearsTime frame: Within 3 months after enrolment.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.